TY  - CONF

T1  - 12-Month Effectiveness and Tolerability of Brivaracetam in the Real-World: The International EXPERIENCE Pooled Analysis (P11-1.003)

JO  - Neurology

UR  - http://dx.doi.org/10.1212/wnl.0000000000201896

PY  - 2023/04/25

AU  - Villanueva V

AU  - D’Souza W

AU  - Faught E

AU  - Klein P

AU  - Reuber M

AU  - Rosenow F

AU  - Salas-Puig J

AU  - Insuga VS

AU  - Strzelczyk A

AU  - Szaflarski JP

AU  - Besson H et al

ED  - 

DO  - DOI: 10.1212/wnl.0000000000201896

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 100

IS  - 17_supplement_2

Y2  - 2024/12/22

ER  -